SMTL ID : 5ho6.1

CRYSTAL STRUCTURE OF CMET IN COMPLEX WITH CMPD.

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.97 Å

Oligo State

monomer

Ligands

1 x 63K: 1-(6-{[6-(4-fluorophenyl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}-1,3-benzothiazol-2-yl)-3-[2-(morpholin-4-yl)ethyl]urea(Non-covalent)

63K.1: 16 residues within 4Å: Chain A: V.44, A.60, L.92, L.109, P.110, Y.111, M.112, K.113, H.114, G.115, D.116, R.160, M.163, A.173, D.174, A.178 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:A.60, A:L.109, A:D.116, A:A.173, A:D.174 Hydrogen bonds: A:Y.111, A:M.112, A:M.112, A:M.112, A:D.174 Water bridges: A:N.123, A:F.175

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ugolini, A. et al., Discovery and Pharmacokinetic and Pharmacological Properties of the Potent and Selective MET Kinase Inhibitor 1-{6-[6-(4-Fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-ylsulfanyl]benzothiazol-2-yl}-3-(2-morpholin-4-ylethyl)urea (SAR125844). J.Med.Chem. (2016)

Release Date

2016-11-23

Peptides

Hepatocyte growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Hepatocyte growth factor receptor

Related Entries With Identical Sequence